Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies

Lezot, F., Chesneau, J., Battaglia, S. et al. (5 more authors) (2014) Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. BONE, 68. pp. 146-152. ISSN 8756-3282

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2014 Elsevier Inc. All rights reserved
Keywords: Zoledronic acid; Tooth eruption; Skull bone formation; Osteosarcoma
Dates:
  • Published: November 2014
  • Published (online): 2 September 2014
  • Accepted: 27 August 2014
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 28 Apr 2016 12:50
Last Modified: 21 Jun 2016 15:36
Published Version: http://dx.doi.org/10.1016/j.bone.2014.08.018
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.bone.2014.08.018
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics